Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IgE-binding molecules on human Langerhans cells.

T Bieber1

  • 1Department of Dermatology, Ludwig-Maximilian University Medical School, Munich, Germany.

Acta Dermato-Venereologica. Supplementum
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European Guideline (EuroGuiDerm) on atopic eczema: Living update.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

First update of the living European guideline (EuroGuiDerm) on atopic eczema.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Upadacitinib for moderate-to-severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same journal

Atopic eczema - new insights in the definition, diagnostics and disease management. Proceedings of a LEO eczema workshop. November 2003. Copenhagen, Denmark.

Acta dermato-venereologica. Supplementum·2006
Same journal

Atopic hand eczema and treatment strategies.

Acta dermato-venereologica. Supplementum·2005
Same journal

Epidemiology and job-related problems for the eczema patient.

Acta dermato-venereologica. Supplementum·2005
Same journal

Treatment strategies and compliance for the adult patient with atopic eczema.

Acta dermato-venereologica. Supplementum·2005
Same journal

Compliance among patients with atopic eczema.

Acta dermato-venereologica. Supplementum·2005
Same journal

Contact allergic reactions in patients with atopic eczema.

Acta dermato-venereologica. Supplementum·2005
See all related articles

Normal human Langerhans cells bind IgE via three molecules: Fc epsilon R2/CD23, IgE-binding protein (epsilon BP), and Fc epsilon RI. Their roles in atopic disease are discussed.

Area of Science:

  • Immunology
  • Dermatology

Background:

  • Normal human Langerhans cells (LC) possess the ability to bind immunoglobulin E (IgE).
  • Understanding IgE-binding molecules on LC is crucial for investigating immune responses.

Purpose of the Study:

  • To review recent data on IgE-binding structures on human Langerhans cells.
  • To discuss the physiological relevance of these structures in the context of atopic disease.

Main Methods:

  • Characterization of IgE-binding molecules on normal human Langerhans cells.
  • Review of current scientific literature on Fc epsilon R2/CD23, epsilon BP, and Fc epsilon RI.

Main Results:

  • Three distinct IgE-binding structures identified on human Langerhans cells: Fc epsilon R2/CD23 (low affinity IgE receptor), IgE-binding protein (epsilon BP, homologous to murine Mac-2 antigen), and Fc epsilon RI (high affinity IgE receptor).

Related Experiment Videos

Conclusions:

  • These IgE-binding molecules on Langerhans cells may play a significant role in the pathogenesis of atopic diseases.
  • Further research into these interactions could lead to novel therapeutic strategies for atopic conditions.